Dynacure

Biotechnology ResearchGrand Est, France11-50 Employees

Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. 
Dynacure is headquartered in Strasbourg, France with a corporate office in Philadelphia, PA, USA. 

Sign up for free to view info Email Format Employee directory